Prokidney (PROK) Assets Average (2021 - 2026)
Prokidney (PROK) reported Assets Average of $314.2 million for Q1 2026, down 25.83% year-over-year from $423.6 million in Q1 2025, and down 8.56% quarter-over-quarter from $343.6 million in Q4 2025.
Prokidney (PROK) Assets Average (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Assets Average data on file, last reported at $314.2 million in Q1 2026.
- Assets Average for Q1 2026 came in at $314.2 million, down 25.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $314.2 million (down 25.83% YoY), and the FY2025 annual result was $388.3 million, down 9.86% from the prior year.
- Assets Average slipped to $314.2 million in Q1 2026 per PROK's latest filing, from $343.6 million in the prior quarter.
- Over five years, Assets Average peaked at $525.2 million in Q4 2022 and troughed at $145.5 million in Q1 2022.
- A 5-year average of $402.3 million and a median of $423.6 million in 2025 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2026: Assets Average jumped 260.06% in 2022, then slipped 25.83% in 2026.
- A 5-year view of Assets Average shows it stood at $525.2 million in 2022, then slipped by 16.95% to $436.2 million in 2023, then rose by 4.99% to $457.9 million in 2024, then retreated by 24.97% to $343.6 million in 2025, then retreated by 8.56% to $314.2 million in 2026.
- Business Quant data shows PROK's Assets Average at $314.2 million in Q1 2026, $343.6 million in Q4 2025, and $361.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | 314.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 314.18 Mn |
| Dec 31, 2025 | 343.59 Mn |
| Sep 30, 2025 | 361.87 Mn |
| Jun 30, 2025 | 389.10 Mn |
| Mar 31, 2025 | 423.57 Mn |
| Dec 31, 2024 | 457.93 Mn |
| Sep 30, 2024 | 486.98 Mn |
| Jun 30, 2024 | 443.46 Mn |
| Mar 31, 2024 | 404.16 Mn |
| Dec 31, 2023 | 436.18 Mn |
| Sep 30, 2023 | 468.01 Mn |
| Jun 30, 2023 | 489.69 Mn |
| Mar 31, 2023 | 506.57 Mn |
| Dec 31, 2022 | 525.22 Mn |
| Sep 30, 2022 | 391.72 Mn |
| Jun 30, 2022 | 250.88 Mn |
| Mar 31, 2022 | 145.53 Mn |
| Dec 31, 2021 | 145.87 Mn |
| Sep 30, 2021 | 126.03 Mn |